Advanced Cancer, Pain & Quality of Life -

Advanced Cancer, Pain & Quality of Life

Edward Chow, Joav Merrick (Herausgeber)

Buch | Hardcover
320 Seiten
2011
Nova Science Publishers Inc (Verlag)
978-1-61668-207-1 (ISBN)
108,55 inkl. MwSt
An estimated 166,400 new cases of cancer occur in Canada in 2008. Bone metastases unfortunately remain a common site of recurrence, with breast and prostate cancer patients representing a substantial proportion of this population. Metastatic bone disease is associated with significant morbidity and mortality.
An estimated 166,400 new cases of cancer will occur in Canada in 2008. Bone metastases unfortunately remain a common site of recurrence, with breast and prostate cancer patients representing a substantial proportion of this population. Metastatic bone disease is associated with significant morbidity and mortality. Pain is experienced by up to two thirds of patients. The prognosis for patients with bone metastases is highly influenced by tumour type, performance status, and the presence of extraosseous disease. The median survival has been significantly longer in breast cancer patients with a first relapse in the axial skeleton (24 months) versus patients with initial relapse in the liver (3 months) (2). Survival after diagnosis of bone metastases is influenced by the subsequent development of extraosseous metastatic sites: 1.6 years versus 2.1 years in patients with bone-only disease.

Joav Merrick, MD, MMedSci, DMSc, (Medical Director, Health Services, Division for Intellectual and Developmental Disabilities, Ministry of Social Affairs and Social Services, Jerusalem, Israel; Division of Adolescent Medicine, KY Childrens Hospital, Department of Pediatrics, Lexington, Kentucky, US; National Institute of Child Health and Human Development, Jerusalem, Israel; Division of Pediatrics, Hadassah Hebrew University Medical Centers, Mt Scopus Campus, Jerusalem, Israel; School of Public Health, Georgia State University, Atlanta, Georgia, US)

Foreword; Introduction: Advanced cancer. Pain & quality of life; Psychodynamic pain management for cancer patients; Improving cancer pain management in the home; Registered nurse awareness of & practice related to cancer pain; The relationship factors between radiation oncologists & hospice professionals that influence cancer pain palliation; (Bisphosphonates in combination with radiotherapy for the treatment of bone metastases; Are baseline ESAS symptoms related to pain response in patients treated with palliative radiotherapy for bone metastases?; Improvement of symptoms following palliative radiation for bone metastases; Pain flare following palliative radiotherapy for symptomatic bone metastases; Exploring the optimal definitions of partial response & pain progression in patients receiving radiation treatment for painful bone metastases; Post procedure radiation therapy after kyphoplasty or vertebroplasty/cementoplasty for bony metastatic disease; Skeletal related events in patients with metastatic bone disease; A critical discussion of symptom clusters in metastatic cancer; Meaningful change in pain scores in the treatment of bone metastases; Multidisciplinary approach to metastatic bone disease; Gender difference in patients with advanced cancer; Is it possible to predict the survival of patients with advanced metastatic cancer?; Projected referral for an out-patient palliative radiotherapy clinic; Utilization of performance scales in an outpatient palliative radiation oncology clinic; Can we measure quality of life for patients with metastatic spinal cord compression (MSCC)?; The European Organization for Research & Treatment of Cancer Quality-of-Life Group Bone Metastases Module (EORTC QLQ-BM22) questionnaire; Quality of life issues in patients with bone metastases; Bone metastases quality of life instrument tool; Surgical stabilization of severely destructive upper cervical lytic bone metastases; Simple bracing for the relief of intractable pain; Cemented hemiarthroplasty, percutaneous acetabular cementoplasty & post operative radiation for a high risk lesion of the hip; About the editors; About the Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Canada; About the National Institute of Child Health & Human development in Israel; About the book series health & human development; Index.

Erscheint lt. Verlag 25.2.2011
Verlagsort New York
Sprache englisch
Maße 260 x 180 mm
Gewicht 816 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-61668-207-8 / 1616682078
ISBN-13 978-1-61668-207-1 / 9781616682071
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00